| Year |
Citation |
Score |
| 2020 |
Huang HH, Ferguson ID, Thornton AM, Bastola P, Lam C, Lin YT, Choudhry P, Mariano MC, Marcoulis MD, Teo CF, Malato J, Phojanakong PJ, Martin TG, Wolf JL, Wong SW, ... ... Wiita AP, et al. Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma. Nature Communications. 11: 1931. PMID 32321912 DOI: 10.1038/S41467-020-15521-4 |
0.308 |
|
| 2018 |
Choudhry P, Galligan D, Wiita AP. Seeking Convergence and Cure with New Myeloma Therapies. Trends in Cancer. 4: 567-582. PMID 30064664 DOI: 10.1016/J.Trecan.2018.05.005 |
0.302 |
|
| 2018 |
Ferguson I, Lam C, Mariano MC, Wang D, Phojanakong P, Toumivaara S, Shao H, Hann BC, Gestwicki J, Wiita AP. Novel Allosteric Inhibitors of Heat Shock Protein 70 As Agents to Probe Protein Homeostasis and Overcome Proteasome Inhibitor Resistance in Multiple Myeloma Blood. 132: 3212-3212. DOI: 10.1182/Blood-2018-99-117401 |
0.332 |
|
| 2017 |
Le Moigne R, Aftab BT, Djakovic S, Dhimolea E, Valle E, Murnane M, King EM, Soriano F, Menon MK, Wu ZY, Wong ST, Lee GJ, Yao B, Wiita AP, Lam C, et al. The p97 inhibitor CB-5083 is a unique disrupter of protein homeostasis in models of Multiple Myeloma. Molecular Cancer Therapeutics. PMID 28878026 DOI: 10.1158/1535-7163.Mct-17-0233 |
0.309 |
|
| 2017 |
Liu TY, Huang HH, Wheeler D, Xu Y, Wells JA, Song YS, Wiita AP. Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics. Cell Systems. PMID 28578850 DOI: 10.1016/J.Cels.2017.05.001 |
0.311 |
|
| 2016 |
Julien O, Zhuang M, Wiita AP, O'Donoghue AJ, Knudsen GM, Craik CS, Wells JA. Quantitative MS-based enzymology of caspases reveals distinct protein substrate specificities, hierarchies, and cellular roles. Proceedings of the National Academy of Sciences of the United States of America. PMID 27006500 DOI: 10.1073/Pnas.1524900113 |
0.346 |
|
| 2014 |
Wiita AP, Seaman JE, Wells JA. Global analysis of cellular proteolysis by selective enzymatic labeling of protein N-termini. Methods in Enzymology. 544: 327-58. PMID 24974296 DOI: 10.1016/B978-0-12-417158-9.00013-3 |
0.357 |
|
| 2009 |
Perez-Jimenez R, Li J, Kosuri P, Sanchez-Romero I, Wiita AP, Rodriguez-Larrea D, Chueca A, Holmgren A, Miranda-Vizuete A, Becker K, Cho SH, Beckwith J, Gelhaye E, Jacquot JP, Gaucher EA, et al. Diversity of chemical mechanisms in thioredoxin catalysis revealed by single-molecule force spectroscopy. Nature Structural & Molecular Biology. 16: 890-6. PMID 19597482 DOI: 10.1038/Nsmb.1627 |
0.786 |
|
| 2008 |
Perez-Jimenez R, Wiita AP, Rodriguez-Larrea D, Kosuri P, Gavira JA, Sanchez-Ruiz JM, Fernandez JM. Force-clamp spectroscopy detects residue co-evolution in enzyme catalysis. The Journal of Biological Chemistry. 283: 27121-9. PMID 18687682 DOI: 10.1074/Jbc.M803746200 |
0.742 |
|
| 2008 |
Koti Ainavarapu SR, Wiita AP, Dougan L, Uggerud E, Fernandez JM. Single-molecule force spectroscopy measurements of bond elongation during a bimolecular reaction. Journal of the American Chemical Society. 130: 6479-87. PMID 18433129 DOI: 10.1021/Ja800180U |
0.775 |
|
| 2008 |
Ainavarapu SR, Wiita AP, Huang HH, Fernandez JM. A single-molecule assay to directly identify solvent-accessible disulfide bonds and probe their effect on protein folding. Journal of the American Chemical Society. 130: 436-7. PMID 18088123 DOI: 10.1021/Ja077851S |
0.783 |
|
| 2008 |
Szoszkiewicz R, Ainavarapu SR, Wiita AP, Perez-Jimenez R, Sanchez-Ruiz JM, Fernandez JM. Dwell time analysis of a single-molecule mechanochemical reaction. Langmuir : the Acs Journal of Surfaces and Colloids. 24: 1356-64. PMID 17999545 DOI: 10.1021/La702368B |
0.752 |
|
| 2007 |
Wiita AP, Perez-Jimenez R, Walther KA, Gräter F, Berne BJ, Holmgren A, Sanchez-Ruiz JM, Fernandez JM. Probing the chemistry of thioredoxin catalysis with force. Nature. 450: 124-7. PMID 17972886 DOI: 10.1038/Nature06231 |
0.746 |
|
| 2007 |
Ainavarapu SR, Brujic J, Huang HH, Wiita AP, Lu H, Li L, Walther KA, Carrion-Vazquez M, Li H, Fernandez JM. Contour length and refolding rate of a small protein controlled by engineered disulfide bonds. Biophysical Journal. 92: 225-33. PMID 17028145 DOI: 10.1529/Biophysj.106.091561 |
0.699 |
|
| 2006 |
Wiita AP, Ainavarapu SR, Huang HH, Fernandez JM. Force-dependent chemical kinetics of disulfide bond reduction observed with single-molecule techniques. Proceedings of the National Academy of Sciences of the United States of America. 103: 7222-7. PMID 16645035 DOI: 10.1073/Pnas.0511035103 |
0.793 |
|
| 2002 |
Kipp RA, Case MA, Wist AD, Cresson CM, Carrell M, Griner E, Wiita A, Albiniak PA, Chai J, Shi Y, Semmelhack MF, McLendon GL. Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners Biochemistry. 41: 7344-7349. PMID 12044166 DOI: 10.1021/Bi0121454 |
0.329 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2017 |
Embry M, Li X, Yu A, Abrahams C, Greenland NY, Wen KW, Jones C, DeAlmeida V, Krimm S, Krueger S, Matheny S, Kline T, Yam A, Stafford R, Wiita AP, et al. CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, SΤRO-001 Blood. 130: 4420-4420. DOI: 10.1182/Blood.V130.Suppl_1.4420.4420 |
0.291 |
|
| 2018 |
Lin YT, Way GP, Mariano MC, Marcoulis M, Ferguson I, Greene CS, Wiita AP. Integrating Phosphoproteomics and Transcriptional Classifiers Reveals "Hidden Signaling" in Multiple Myeloma Including Differential KRAS and NRAS Mutant Effects Blood. 132: 469-469. DOI: 10.1182/Blood-2018-99-113683 |
0.284 |
|
| 2016 |
Lam C, Murnane M, Smith GA, Taunton J, Aftab BT, Wiita AP. Tofacitinib Reverses Growth Promoting Effects of the Bone Marrow Stromal Environment Though Inhibition of JAK1/STAT3 Signaling in Multiple Myeloma Blood. 128: 2098-2098. DOI: 10.1182/Blood.V128.22.2098.2098 |
0.281 |
|
| 2020 |
Kambhampati S, Wiita AP. Lessons Learned from Proteasome Inhibitors, the Paradigm for Targeting Protein Homeostasis in Cancer. Advances in Experimental Medicine and Biology. 1243: 147-162. PMID 32297217 DOI: 10.1007/978-3-030-40204-4_10 |
0.279 |
|
| 2018 |
Choudhry P, Mariano MC, Wiita AP. DNA Methyltransferase Inhibitors Increase Expression of CD38 and Enhance Daratumumab Efficacy in Multiple Myeloma Blood. 132: 5618-5618. DOI: 10.1182/Blood-2018-99-114206 |
0.279 |
|
| 2018 |
Abrahams CL, Li X, Embry M, Yu A, Krimm S, Krueger S, Greenland NY, Wen KW, Jones C, DeAlmeida V, Solis WA, Matheny S, Kline T, Yam AY, Stafford R, ... Wiita AP, et al. Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001. Oncotarget. 9: 37700-37714. PMID 30701025 DOI: 10.18632/Oncotarget.26491 |
0.278 |
|
| 2018 |
Ramkumar P, Leong J, Seyler M, Georgoulis SJ, Hyrenius Wittsten A, Choudhry P, Roybal K, Wiita AP, Kampmann M. Identifying Factors in Multiple Myeloma Controlling Response to B-Cell Maturation Antigen (BCMA)-Targeted Immunotherapy Using CRISPR-Based Functional Genomics Blood. 132: 1926-1926. DOI: 10.1182/Blood-2018-99-115368 |
0.275 |
|
| 2017 |
Buelow B, Pham D, Choudhry P, Dang K, Pratap P, Clarke S, Harris K, Jorgensen B, Aldred SF, Schellenberger U, Shah N, Trinklein N, Wiita AP, Iyer S, Schooten WV. T Cell Engagement without Cytokine Storm: A Novel Bcma x CD3 Antibody Killing Myeloma Cells with Minimal Cytokine Secretion Blood. 130: 501-501. DOI: 10.1182/Blood.V130.Suppl_1.501.501 |
0.273 |
|
| 2020 |
Chan LN, Murakami MA, Robinson ME, Caeser R, Sadras T, Lee J, Cosgun KN, Kume K, Khairnar V, Xiao G, Ahmed MA, Aghania E, Deb G, Hurtz C, Shojaee S, ... ... Wiita AP, et al. Signalling input from divergent pathways subverts B cell transformation. Nature. PMID 32699415 DOI: 10.1038/S41586-020-2513-4 |
0.272 |
|
| 2019 |
Chan LN, Murakami MA, Caesar R, Hurtz C, Kume K, Sadras T, Shojaee S, Pölönen P, Ugale A, Lee J, Cosgun KN, Geng H, Heinäniemi M, Lohi O, Wiita AP, et al. Signaling Input from Divergent Pathways Subverts Malignant B-Cell Transformation Blood. 134: 3944-3944. DOI: 10.1182/Blood-2019-130774 |
0.272 |
|
| 2015 |
Murnane M, Dhimolea E, Li R, Bariteau MA, Wheeler DD, Akhurst RJ, Logan AC, Munster P, Wiita A, Martin TG, Wolf JL, Liu JO, Mitsiades CS, Aftab BT. Defining Primary Marrow Microenvironment-Induced Synthetic Lethality and Resistance for 2,684 Approved Drugs Across Molecularly Distinct Forms of Multiple Myeloma Blood. 126: 503-503. DOI: 10.1182/Blood.V126.23.503.503 |
0.271 |
|
| 2019 |
Spector JD, Wiita AP. ClinTAD: a tool for copy number variant interpretation in the context of topologically associated domains. Journal of Human Genetics. PMID 30765865 DOI: 10.1038/S10038-019-0573-9 |
0.269 |
|
| 2014 |
Wiita AP, Hsu GW, Lu CM, Esensten JH, Wells JA. Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling. Proceedings of the National Academy of Sciences of the United States of America. 111: 7594-9. PMID 24821784 DOI: 10.1073/Pnas.1405987111 |
0.269 |
|
| 2013 |
Wiita AP, Ziv E, Wiita PJ, Urisman A, Julien O, Burlingame AL, Weissman JS, Wells JA. Global cellular response to chemotherapy-induced apoptosis. Elife. 2: e01236. PMID 24171104 DOI: 10.7554/Elife.01236 |
0.267 |
|
| 2020 |
Leidal AM, Huang HH, Marsh T, Solvik T, Zhang D, Ye J, Kai F, Goldsmith J, Liu JY, Huang YH, Monkkonen T, Vlahakis A, Huang EJ, Goodarzi H, Yu L, ... Wiita AP, et al. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nature Cell Biology. PMID 31932738 DOI: 10.1038/S41556-019-0450-Y |
0.263 |
|
| 2014 |
Carr SA, Abbatiello SE, Ackermann BL, Borchers C, Domon B, Deutsch EW, Grant RP, Hoofnagle AN, Hüttenhain R, Koomen JM, Liebler DC, Liu T, MacLean B, Mani DR, Mansfield E, ... ... Wiita A, et al. Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Molecular & Cellular Proteomics : McP. 13: 907-17. PMID 24443746 DOI: 10.1074/Mcp.M113.036095 |
0.262 |
|
| 2019 |
Lin YT, Way GP, Barwick BG, Mariano MC, Marcoulis M, Ferguson ID, Driessen C, Boise LH, Greene CS, Wiita AP. Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma. Blood Advances. 3: 3214-3227. PMID 31698452 DOI: 10.1182/Bloodadvances.2019000303 |
0.261 |
|
| 2019 |
Nix M, Lin YT, Geng H, Marcoulis M, Phojanakong P, Wang D, Steri V, Whitman J, Bapat S, Stieglitz E, Deucher A, White KL, Hann BC, Wiita AP. In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell Malignancies Blood. 134: 1337-1337. DOI: 10.1182/Blood-2019-130938 |
0.259 |
|
| 2019 |
Lorentsen K, Sankaran P, Trinklein ND, Pham D, Schellenberger U, Buelow B, Boudreau A, Choudhry P, Clarke SC, Dang K, Harris KE, Iyer S, Jorgensen B, Pratap P, Rangaswamy US, ... ... Wiita AP, et al. Abstract 1554: Uncoupling tumor-cell cytotoxicity from cytokine release with novel T-cell engaging bispecific antibodies Cancer Research. 79: 1554-1554. DOI: 10.1158/1538-7445.Am2019-1554 |
0.259 |
|
| 2018 |
Buelow B, Choudhry P, Clarke S, Dang K, Davison L, Force Aldred S, Harris K, Pham D, Pratap P, Rangaswamy U, Schellenberger U, Shah N, Trinklein N, Ugamraj H, Wiita A, et al. Development of a fully human t-cell engaging bispecific antibody for the treatment of multiple myeloma. Journal of Clinical Oncology. 36: 60-60. DOI: 10.1200/Jco.2018.36.5_Suppl.60 |
0.258 |
|
| 2016 |
Sherbenou DW, Aftab BT, Su Y, Behrens CR, Wiita AP, Logan AC, Acosta-Alvear D, Hann BC, Walter P, Wu X, Atkinson JP, Wolf JL, Martin TG, Liu B. CD46 Is Amplified in High-Risk Myeloma with Gain of Chromosome 1q and Selectively Targeted By a Novel Anti-CD46 Antibody-Drug Conjugate Blood. 128: 384-384. DOI: 10.1182/Blood.V128.22.384.384 |
0.257 |
|
| 2019 |
Choudhry P, Mariano MC, Geng H, Martin TG, Wolf JL, Wong SW, Shah N, Wiita AP. DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma. Leukemia. PMID 31595037 DOI: 10.1038/S41375-019-0587-5 |
0.254 |
|
| 2018 |
Lee J, Geng H, Dinson DS, Xiao G, Cosgun KN, Chan LN, Chen Z, Farzan M, Jung JU, Wiita AP, Muschen M. IFITM3-Mediated Regulation of Cell Membrane Dynamics Is Essential for Malignant B-Cell Transformation Blood. 132: 552-552. DOI: 10.1182/Blood-2018-99-117472 |
0.254 |
|
| 2020 |
Ramkumar P, Abarientos AB, Tian R, Seyler M, Leong JT, Chen M, Choudhry P, Hechler T, Shah N, Wong SW, Martin TG, Wolf JL, Roybal KT, Pahl A, Taunton J, ... Wiita AP, et al. CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma. Blood Advances. 4: 2899-2911. PMID 32589729 DOI: 10.1182/Bloodadvances.2019001346 |
0.252 |
|
| 2013 |
Miller S, Wiita A, Wright C, Reyes H, Liu C. Evaluation of Glutamate Dehydrogenase Immunoassay Screening with Toxin Confirmation for the Diagnosis of Clostridium difficile Infection Labmedicine. 44. DOI: 10.1309/Lm31Zx1Pfrztgjui |
0.252 |
|
| 2018 |
Lam C, Ferguson ID, Mariano MC, Lin YT, Murnane M, Liu H, Smith GA, Wong SW, Taunton J, Liu JO, Mitsiades CS, Hann BC, Aftab BT, Wiita AP. Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica. PMID 29622655 DOI: 10.3324/Haematol.2017.174482 |
0.251 |
|
| 2019 |
Trinklein ND, Pham D, Schellenberger U, Buelow B, Boudreau A, Choudhry P, Clarke SC, Dang K, Harris KE, Iyer S, Jorgensen B, Pratap PP, Rangaswamy US, Ugamraj HS, Vafa O, ... Wiita AP, et al. Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies. Mabs. PMID 30698484 DOI: 10.1080/19420862.2019.1574521 |
0.25 |
|
| 2019 |
Lee J, Xiao G, Cosgun KNN, Geng H, Ma N, Chan LN, Kume K, Nix M, Chen Z, Chen CD, Chen J, Khairnar V, Wiita AP, Thomas-Tikhonenko A, Farzan M, et al. Ifitm3 Is Essential for PI(3,4,5)P3-Dependent B-Cell Activation and Leukemogenesis Blood. 134: 2782-2782. DOI: 10.1182/Blood-2019-127615 |
0.25 |
|
| 2020 |
Kambhampati S, Wen KW, Sung V, Wong SWK, Martin TG, Wolf JL, Shah N, Wiita A. Investigating macrophage function as a mechanism of resistance to daratumumab in relapsed refractory multiple myeloma patients. Journal of Clinical Oncology. 38: e20547-e20547. DOI: 10.1200/Jco.2020.38.15_Suppl.E20547 |
0.248 |
|
| 2020 |
Sarin V, Yu K, Ferguson ID, Gugliemini O, Nix MA, Hann B, Sirota M, Wiita AP. Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis. Leukemia. PMID 32123307 DOI: 10.1016/J.Clml.2019.09.120 |
0.245 |
|
| 2016 |
Sherbenou DW, Aftab BT, Su Y, Behrens CR, Wiita A, Logan AC, Acosta-Alvear D, Hann BC, Walter P, Shuman MA, Wu X, Atkinson JP, Wolf JL, Martin TG, Liu B. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. The Journal of Clinical Investigation. PMID 27841764 DOI: 10.1172/Jci85856 |
0.244 |
|
| 2016 |
Mather C, Qi Z, Wiita AP. False Positive Cell Free DNA Screening for Microdeletions Due to Non-Pathogenic Copy Number Variants. Prenatal Diagnosis. PMID 27061292 DOI: 10.1002/Pd.4823 |
0.242 |
|
| 2011 |
Wiita AP, Schrijver I. Clinical application of high throughput molecular screening techniques for pharmacogenomics. Pharmacogenomics and Personalized Medicine. 4: 109-21. PMID 23226057 DOI: 10.2147/Pgpm.S15302 |
0.241 |
|
| 2019 |
Ferguson I, Lin YT, Tuomivaara S, Wolf JL, Martin TG, Wong SW, Shah ND, Driessen C, Ness BGV, Wiita AP. Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and –Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and Biology Blood. 134: 1803-1803. DOI: 10.1182/Blood-2019-131681 |
0.24 |
|
| 2020 |
Han LM, Grenert JP, Wiita AP, Quinn M, Fujimoto VY, Rabban JT. Prevalence of Partial Hydatidiform Mole in Products of Conception From Gestations With Fetal Triploidy Merits Reflex Genotype Testing Independent of the Morphologic Appearance of the Chorionic Villi. The American Journal of Surgical Pathology. PMID 32205485 DOI: 10.1097/Pas.0000000000001466 |
0.236 |
|
| 2012 |
Wiita AP, Nambiar A. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME). Transfusion. 52: 2146-54. PMID 23113654 DOI: 10.1111/J.1537-2995.2012.03593.X |
0.235 |
|
| 2020 |
Guo X, Aviles G, Liu Y, Tian R, Unger BA, Lin YT, Wiita AP, Xu K, Correia MA, Kampmann M. Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway. Nature. PMID 32132707 DOI: 10.1038/S41586-020-2078-2 |
0.231 |
|
| 2018 |
Goode B, Mondal G, Hyun M, Ruiz DG, Lin YH, Van Ziffle J, Joseph NM, Onodera C, Talevich E, Grenert JP, Hewedi IH, Snuderl M, Brat DJ, Kleinschmidt-DeMasters BK, Rodriguez FJ, ... ... Wiita AP, et al. A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle. Nature Communications. 9: 810. PMID 29476136 DOI: 10.1038/S41467-018-02826-8 |
0.224 |
|
| 2019 |
Crottès D, Lin YT, Peters CJ, Gilchrist JM, Wiita AP, Jan YN, Jan LY. TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 31182586 DOI: 10.1073/Pnas.1900703116 |
0.224 |
|
| 2012 |
Wiita AP, Roubinian N, Khan Y, Chin-Hong PV, Singer JP, Golden JA, Miller S. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis. Transplant Infectious Disease : An Official Journal of the Transplantation Society. 14: 248-58. PMID 22385394 DOI: 10.1111/J.1399-3062.2012.00723.X |
0.222 |
|
| 2019 |
Choudhry P, Mariano M, Geng H, Wiita A. DNA methyltransferase inhibitors upregulate CD38 expression and enhance daratumumab efficacy in multiple myeloma Clinical Lymphoma, Myeloma & Leukemia. 19. DOI: 10.1016/J.Clml.2019.09.241 |
0.219 |
|
| 2019 |
Ha TK, Mardy AH, Beleford D, Spanier A, Wayman BV, Penon-Portmann M, Wiita AP, Shieh JT. X-linked duplication copy number variation in a familial overgrowth condition. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. PMID 31762227 DOI: 10.1002/Ajmg.C.31756 |
0.218 |
|
| 2016 |
Ori-McKenney KM, McKenney RJ, Huang HH, Li T, Meltzer S, Jan LY, Vale RD, Wiita AP, Jan YN. Phosphorylation of β-Tubulin by the Down Syndrome Kinase, Minibrain/DYRK1a, Regulates Microtubule Dynamics and Dendrite Morphogenesis. Neuron. PMID 27112495 DOI: 10.1016/J.Neuron.2016.03.027 |
0.217 |
|
| 2018 |
Buelow B, Choudry P, Clarke S, Dang K, Davison L, Force Aldred S, Harris K, Pratap P, Pham D, Rangaswamy U, Schellenberger U, Shah N, Trinklein N, Ugamraj H, Wiita A, et al. Pre-clinical development of TNB-383B, a fully human T-cell engaging bispecific antibody targeting BCMA for the treatment of multiple myeloma. Journal of Clinical Oncology. 36: 8034-8034. DOI: 10.1200/Jco.2018.36.15_Suppl.8034 |
0.215 |
|
| 2020 |
Mardy AH, Wiita AP, Wayman BV, Drexler K, Sparks TN, Norton ME. Variants of uncertain significance in prenatal microarrays: a retrospective cohort study. Bjog : An International Journal of Obstetrics and Gynaecology. PMID 32702189 DOI: 10.1111/1471-0528.16427 |
0.214 |
|
| 2017 |
Qi Z, Madaan S, Chetty S, Yu J, Wiita AP. False Negative Fetal Cell Free DNA Screening for Microdeletion Syndromes in the Presence of an Unbalanced Translocation Involving Monosomy 4p. Prenatal Diagnosis. PMID 28207935 DOI: 10.1002/Pd.5027 |
0.213 |
|
| 2017 |
Deshpande A, Yadav S, Dao DQ, Wu ZY, Hokanson KC, Cahill MK, Wiita AP, Jan YN, Ullian EM, Weiss LA. Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder. Cell Reports. 21: 2678-2687. PMID 29212016 DOI: 10.1016/J.Celrep.2017.11.037 |
0.212 |
|
| 2017 |
Wiita A, Liu H, Lam C, Jandeleit B, Fischer W, Koller K, Hann B. Hijacking Myeloma Metabolism to Target Cytotoxic Chemotherapy to Malignant Plasma Cells With Decreased Bone Marrow Toxicity Clinical Lymphoma, Myeloma & Leukemia. 17. DOI: 10.1016/J.Clml.2017.03.096 |
0.21 |
|
| 2018 |
Whitman J, Ng D, Nix M, Leung K, Balassanian R, Wiita A. Fine Needle Aspiration is an Effective Method for Cell Surface Proteomics: Towards a Personalized Cancer Surfaceome Journal of the American Society of Cytopathology. 7. DOI: 10.1016/J.Jasc.2018.06.013 |
0.206 |
|
| 2013 |
Wiita AP, Ziv E, Wiita PJ, Urisman A, Julien O, Burlingame AL, Weissman JS, Wells JA. Correction: Global cellular response to chemotherapy-induced apoptosis Elife. 2. DOI: 10.7554/Elife.01816 |
0.198 |
|
| 2019 |
Mardy AH, Sparks TN, Wiita AP, Drexler K, Wayman BV, Nadel A, Norton ME. 880: Variants of uncertain significance in prenatal microarrays American Journal of Obstetrics and Gynecology. 220. DOI: 10.1016/J.Ajog.2018.11.904 |
0.196 |
|
| 2023 |
Tuomivaara ST, Teo CF, Jan YN, Jan LY, Wiita AP. SLAPSHOT reveals rapid dynamics of extracellularly exposed proteome in response to calcium-activated plasma membrane phospholipid scrambling. Biorxiv : the Preprint Server For Biology. PMID 36993417 DOI: 10.1101/2023.03.26.534250 |
0.195 |
|
| 2013 |
Wiita AP, Ziv E, Wiita PJ, Urisman A, Julien O, Burlingame AL, Weissman JS, Wells JA. Author response: Global cellular response to chemotherapy-induced apoptosis Elife. DOI: 10.7554/Elife.01236.036 |
0.183 |
|
| 2023 |
Mandal K, Wicaksono G, Yu C, Adams JJ, Hoopmann MR, Temple WC, Izgutdina A, Escobar BP, Gorelik M, Ihling CH, Nix MA, Naik A, Xie WH, Hübner J, Rollins LA, ... ... Wiita AP, et al. Structural surfaceomics reveals an AML-specific conformation of integrin β as a CAR T cellular therapy target. Nature Cancer. PMID 37904046 DOI: 10.1038/s43018-023-00652-6 |
0.157 |
|
| 2022 |
Patiño-Escobar B, Ferguson ID, Wiita AP. Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance. Cell Stress. 6: 89-92. PMID 36311892 DOI: 10.15698/cst2022.11.273 |
0.136 |
|
| 2022 |
Ferguson ID, Patiño-Escobar B, Tuomivaara ST, Lin YT, Nix MA, Leung KK, Kasap C, Ramos E, Nieves Vasquez W, Talbot A, Hale M, Naik A, Kishishita A, Choudhry P, Lopez-Girona A, ... ... Wiita AP, et al. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nature Communications. 13: 4121. PMID 35840578 DOI: 10.1038/s41467-022-31810-6 |
0.133 |
|
| 2023 |
Naik A, Srivastava S, Wiita AP. "Cell Surface Capture" Workflow for Label-Free Quantification of the Cell Surface Proteome. Journal of Visualized Experiments : Jove. PMID 37036222 DOI: 10.3791/64952 |
0.129 |
|
| 2023 |
Patiño-Escobar B, Talbot A, Wiita AP. Overcoming proteasome inhibitor resistance in the immunotherapy era. Trends in Pharmacological Sciences. 44: 507-518. PMID 37344251 DOI: 10.1016/j.tips.2023.05.006 |
0.127 |
|
| 2020 |
Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Lim SA, Zha S, Yamin R, Kao K, Rosenberg OS, Ravetch JV, Wiita AP, et al. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 32766586 DOI: 10.1101/2020.07.31.231746 |
0.126 |
|
| 2020 |
Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Zha S, Yamin R, Kao K, Rosenberg OS, Ravetch JV, Wiita AP, Leung KK, et al. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America. PMID 33093202 DOI: 10.1073/pnas.2016093117 |
0.121 |
|
| 2022 |
Sharma A, Nair R, Achreja A, Mittal A, Gupta P, Balakrishnan K, Edgar CL, Animasahun O, Dwivedi B, Barwick BG, Gupta VA, Matulis SM, Bhasin M, Lonial S, Nooka AK, ... Wiita AP, et al. Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma. Science Advances. 8: eabq5575. PMID 36170375 DOI: 10.1126/sciadv.abq5575 |
0.116 |
|
| 2020 |
Lee J, Robinson ME, Ma N, Artadji D, Ahmed MA, Xiao G, Sadras T, Deb G, Winchester J, Cosgun KN, Geng H, Chan LN, Kume K, Miettinen TP, Zhang Y, ... ... Wiita AP, et al. IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells. Nature. PMID 33149299 DOI: 10.1038/s41586-020-2884-6 |
0.11 |
|
| 2022 |
Ferguson ID, Lin YT, Lam C, Shao H, Tharp KM, Hale M, Kasap C, Mariano MC, Kishishita A, Patiño Escobar B, Mandal K, Steri V, Wang D, Phojanakong P, Tuomivaara ST, ... ... Wiita AP, et al. Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma. Cell Chemical Biology. PMID 35853457 DOI: 10.1016/j.chembiol.2022.06.010 |
0.107 |
|
| 2023 |
Ge AY, Huang CY, Banerjee R, Knoche J, Chung A, Arora S, Martin TG, Wolf J, Wong SW, Wiita AP, Shah N. Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective study. British Journal of Haematology. PMID 36846905 DOI: 10.1111/bjh.18711 |
0.104 |
|
| 2023 |
Wadhwa A, Wang S, Patiño-Escobar B, Bidkar AP, Bobba KN, Chan E, Meher N, Bidlingmaier S, Su Y, Dhrona S, Geng H, Sarin V, VanBrocklin HF, Wilson DM, He J, ... ... Wiita AP, et al. CD46-targeted theranostics for Positron Emission Tomography and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38109209 DOI: 10.1158/1078-0432.CCR-23-2130 |
0.104 |
|
| 2021 |
Liu JY, Lin YT, Leidal AM, Huang HH, Ye J, Wiita AP, Debnath J. GRASP55 restricts early-stage autophagy and regulates spatial organization of the early secretory network. Biology Open. PMID 34533192 DOI: 10.1242/bio.058736 |
0.101 |
|
| 2022 |
Kai F, Ou G, Tourdot RW, Stashko C, Gaietta G, Swift MF, Volkmann N, Long AF, Han Y, Huang HH, Northey JJ, Leidal AM, Viasnoff V, Bryant DM, Guo W, ... Wiita AP, et al. ECM dimensionality tunes actin tension to modulate endoplasmic reticulum function and spheroid phenotypes of mammary epithelial cells. The Embo Journal. e109205. PMID 35880301 DOI: 10.15252/embj.2021109205 |
0.1 |
|
| 2024 |
Nejo T, Wang L, Leung KK, Wang A, Lakshmanachetty S, Gallus M, Kwok DW, Hong C, Chen LH, Carrera DA, Zhang MY, Stevers NO, Maldonado GC, Yamamichi A, Watchmaker PB, ... ... Wiita AP, et al. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma. Scientific Reports. 14: 6362. PMID 38493204 DOI: 10.1038/s41598-024-56684-0 |
0.097 |
|
| 2024 |
Kasap C, Izgutdina A, Patiño-Escobar B, Kang A, Chilakapati N, Akagi N, Johnson H, Rashid T, Werner J, Barpanda A, Geng H, Lin YT, Rampersaud S, Gil-Alós D, Sobh A, ... ... Wiita AP, et al. Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells. Biorxiv : the Preprint Server For Biology. PMID 38463958 DOI: 10.1101/2024.02.24.581875 |
0.095 |
|
| 2020 |
Spector JD, Wiita AP. A Guide to Using ClinTAD for Interpretation of DNA Copy Number Variants in the Context of Topologically Associated Domains. Current Protocols in Human Genetics. 108: e106. PMID 33170544 DOI: 10.1002/cphg.106 |
0.094 |
|
| 2023 |
Kwok DW, Stevers NO, Nejo T, Chen LH, Etxeberria I, Jung J, Okada K, Cove MC, Lakshmanachetty S, Gallus M, Barpanda A, Hong C, Chan GKL, Wu SH, Ramos E, ... ... Wiita AP, et al. Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens. Biorxiv : the Preprint Server For Biology. PMID 37904942 DOI: 10.1101/2023.10.19.563178 |
0.091 |
|
| 2024 |
Nix MA, Wiita AP. Alternative target recognition elements for chimeric antigen receptor (CAR) T cells: beyond standard antibody fragments. Cytotherapy. PMID 38466264 DOI: 10.1016/j.jcyt.2024.02.024 |
0.088 |
|
| 2021 |
Nix MA, Mandal K, Geng H, Paranjape N, Lin YT, Rivera J, Marcoulis M, White KL, Whitman JD, Bapat SP, Parker KR, Ramirez J, Deucher A, Phojanokong P, Steri V, ... ... Wiita AP, et al. Surface proteomics reveals CD72 as a target for in vitro-evolved nanobody-based CAR-T cells in KMT2A/MLL1-rearranged B-ALL. Cancer Discovery. PMID 33727310 DOI: 10.1158/2159-8290.CD-20-0242 |
0.087 |
|
| 2023 |
Temple WC, Nix MA, Naik A, Izgutdina A, Huang BJ, Wicaksono G, Phojanakong P, Serrano JAC, Young EP, Ramos E, Salangsang F, Steri V, Xirenayi S, Hermiston M, Logan AC, ... ... Wiita AP, et al. Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies. Journal For Immunotherapy of Cancer. 11. PMID 38007238 DOI: 10.1136/jitc-2023-006985 |
0.087 |
|
| 2021 |
Bigley AB, Spade S, Agha NH, Biswas S, Tang S, Malik MH, Dai L, Masoumi S, Patiño-Escobar B, Hale M, DiPierro G, Martell R, Hann B, Shah N, Wiita AP, et al. FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma. Blood Advances. 5: 3021-3031. PMID 34357379 DOI: 10.1182/bloodadvances.2020002440 |
0.086 |
|
| 2023 |
Paranjape N, Lin YT, Flores-Ramirez Q, Sarin V, Johnson AB, Chu J, Paredes M, Wiita AP. A CRISPR-engineered isogenic model of the 22q11.2 A-B syndromic deletion. Scientific Reports. 13: 7689. PMID 37169815 DOI: 10.1038/s41598-023-34325-2 |
0.074 |
|
| 2022 |
Solvik TA, Nguyen TA, Tony Lin YH, Marsh T, Huang EJ, Wiita AP, Debnath J, Leidal AM. Secretory autophagy maintains proteostasis upon lysosome inhibition. The Journal of Cell Biology. 221. PMID 35446347 DOI: 10.1083/jcb.202110151 |
0.072 |
|
| 2023 |
Gökbuget D, Lenshoek K, Boileau RM, Bayerl J, Huang H, Wiita AP, Laird DJ, Blelloch R. Transcriptional repression upon S phase entry protects genome integrity in pluripotent cells. Nature Structural & Molecular Biology. 30: 1561-1570. PMID 37696959 DOI: 10.1038/s41594-023-01092-7 |
0.069 |
|
| 2024 |
Shin D, Kim CN, Ross J, Hennick KM, Wu SR, Paranjape N, Leonard R, Wang JC, Keefe MG, Pavlovic BJ, Donohue KC, Moreau C, Wigdor EM, Larson HH, Allen DE, ... ... Wiita AP, et al. Thalamocortical organoids enable in vitro modeling of 22q11.2 microdeletion associated with neuropsychiatric disorders. Cell Stem Cell. PMID 38382530 DOI: 10.1016/j.stem.2024.01.010 |
0.058 |
|
| 2023 |
Nejo T, Wang L, Leung KK, Wang A, Lakshmanachetty S, Gallus M, Kwok DW, Hong C, Chen LH, Carrera DA, Zhang MY, Stevers NO, Maldonado GC, Yamamichi A, Watchmaker P, ... ... Wiita AP, et al. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma. Biorxiv : the Preprint Server For Biology. PMID 37961484 DOI: 10.1101/2023.10.26.564156 |
0.057 |
|
| 2024 |
Leng K, Cadwell CR, Devine WP, Tihan T, Qi Z, Singhal NS, Glenn OA, Kamiya S, Wiita AP, Berger AC, Shieh JT, Titus EW, Paredes MF, Upadhyay V. Cell-Type Specificity of Mosaic Chromosome 1q Gain Resolved by snRNA-seq in a Case of Epilepsy With Hyaline Protoplasmic Astrocytopathy. Neurology. Genetics. 10: e200142. PMID 38586598 DOI: 10.1212/NXG.0000000000200142 |
0.053 |
|
| 2024 |
Leng K, Cadwell CR, Devine WP, Tihan T, Qi Z, Singhal N, Glenn O, Kamiya S, Wiita A, Berger A, Shieh JT, Titus EW, Paredes MF, Upadhyay V. Cell type specificity of mosaic chromosome 1q gain resolved by snRNA-seq in a case of epilepsy with hyaline protoplasmic astrocytopathy. Biorxiv : the Preprint Server For Biology. PMID 38328093 DOI: 10.1101/2023.10.16.562560 |
0.053 |
|
| 2021 |
Lee J, Robinson ME, Ma N, Artadji D, Ahmed MA, Xiao G, Sadras T, Deb G, Winchester J, Cosgun KN, Geng H, Chan LN, Kume K, Miettinen TP, Zhang Y, ... ... Wiita AP, et al. Author Correction: IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells. Nature. PMID 33712811 DOI: 10.1038/s41586-021-03388-4 |
0.048 |
|
| Hide low-probability matches. |